Literature DB >> 14688392

Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.

Yair Gazitt1, Cagla Akay.   

Abstract

Adhesion molecules and stromal cell-derived factor-1 (SDF-1)/CXCR4 signaling play key roles in homing and mobilization of hematopoietic stem cells (HSC). Active signaling through SDF-1/CXCR4 and upregulation of adhesion molecules are required for homing, whereas downregulation of adhesion molecules and disruption of SDF-1/CXCR4 signaling are required for mobilization of HSC. We studied the surface expression of CXCR4 very late activation antigen (VLA)-4 and VLA-5 on myeloma cells mobilized with cyclophosphamide and GM-CSF in 12 multiple myeloma patients undergoing HSC mobilization for autologous transplantation. We also studied the plasma levels of SDF-1 in apheresis collection of these patients. We observed a statistically significant decrease in the levels of SDF-1 and surface expression of CXCR4 on myeloma cells in four consecutive apheresis collections compared with premobilization bone marrow specimens. We also observed a statistically significant decrease in surface expression of VLA-4 in myeloma cells in the apheresis collections compared with premobilization bone marrow samples. Furthermore, myeloma cells derived from apheresis collections had decreased adhesion and trans-stromal migration in response to SDF-1, which could be reversed by short incubation with interleukin-6. Hence, mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688392     DOI: 10.1634/stemcells.22-1-65

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  16 in total

1.  Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.

Authors:  Yazan Alsayed; Hai Ngo; Judith Runnels; Xavier Leleu; Ujjal K Singha; Costas M Pitsillides; Joel A Spencer; Teresa Kimlinger; Joanna M Ghobrial; Xiaoying Jia; Ganwei Lu; Michael Timm; Ashok Kumar; Daniel Côté; Israel Veilleux; Karen E Hedin; G David Roodman; Thomas E Witzig; Andrew L Kung; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

Review 2.  Myelomagenesis: capturing early microenvironment changes.

Authors:  Neha Korde; Irina Maric
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

3.  Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma.

Authors:  Pilar de la Puente; Nancy Quan; Ryan Soo Hoo; Barbara Muz; Rebecca C Gilson; Micah Luderer; Justin King; Samuel Achilefu; Noha Nabil Salama; Ravi Vij; Abdel Kareem Azab
Journal:  Haematologica       Date:  2016-04-14       Impact factor: 9.941

Review 4.  Chemokines in multiple myeloma.

Authors:  Rohit Aggarwal; Irene M Ghobrial; G David Roodman
Journal:  Exp Hematol       Date:  2006-10       Impact factor: 3.084

5.  SDF-1α stiffens myeloma bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II.

Authors:  Dong Soon Choi; Daniel J Stark; Robert M Raphael; Jianguo Wen; Jing Su; Xiaobo Zhou; Chung-Che Chang; Youli Zu
Journal:  Int J Cancer       Date:  2014-09-02       Impact factor: 7.396

6.  BTK induces CAM-DR through regulation of CXCR4 degradation in multiple myeloma.

Authors:  Wang Wang; Rongfang Wei; Shijia Liu; Li Qiao; Jianhao Hou; Chunyan Gu; Ye Yang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

7.  Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.

Authors:  Shuxian Jiang; Meritxell Alberich-Jorda; Radoslaw Zagozdzon; Kalindi Parmar; Yigong Fu; Peter Mauch; Naheed Banu; Alexandros Makriyannis; Daniel G Tenen; Shalom Avraham; Jerome E Groopman; Hava Karsenty Avraham
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

8.  Granulocyte colony-stimulating factor enhances bone marrow mononuclear cell homing to the liver in a mouse model of acute hepatic injury.

Authors:  Shi-Zhu Jin; Xiang-Wei Meng; Xun Sun; Ming-Zi Han; Bing-Rong Liu; Xin-Hong Wang; Li-Ying Sun; Qi Huang; Rui-Bo Zhao; Xiang Ban; Hong-Ying Yu; Hong-Wei Yu
Journal:  Dig Dis Sci       Date:  2010-02-04       Impact factor: 3.199

9.  Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.

Authors:  Sally K Martin; Peter Diamond; Sharon A Williams; Luen Bik To; Daniel J Peet; Nobutaka Fujii; Stan Gronthos; Adrian L Harris; Andrew C W Zannettino
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

10.  Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?

Authors:  J E Noll; S A Williams; L E Purton; A C W Zannettino
Journal:  Blood Cancer J       Date:  2012-09-14       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.